IBDEI0MA ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10172,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,10172,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,10172,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,10173,0)
 ;;=L29.9^^68^664^251
 ;;^UTILITY(U,$J,358.3,10173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10173,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,10173,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,10173,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,10174,0)
 ;;=L30.0^^68^664^232
 ;;^UTILITY(U,$J,358.3,10174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10174,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,10174,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,10174,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,10175,0)
 ;;=L30.1^^68^664^140
 ;;^UTILITY(U,$J,358.3,10175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10175,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,10175,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,10175,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,10176,0)
 ;;=L30.2^^68^664^132
 ;;^UTILITY(U,$J,358.3,10176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10176,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,10176,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,10176,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,10177,0)
 ;;=L30.4^^68^664^144
 ;;^UTILITY(U,$J,358.3,10177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10177,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,10177,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,10177,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,10178,0)
 ;;=L30.8^^68^664^135
 ;;^UTILITY(U,$J,358.3,10178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10178,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,10178,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,10178,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,10179,0)
 ;;=L30.9^^68^664^136
 ;;^UTILITY(U,$J,358.3,10179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10179,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,10179,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,10179,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,10180,0)
 ;;=L40.0^^68^664^253
 ;;^UTILITY(U,$J,358.3,10180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10180,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,10180,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,10180,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,10181,0)
 ;;=L40.1^^68^664^256
 ;;^UTILITY(U,$J,358.3,10181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10181,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,10181,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,10181,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,10182,0)
 ;;=L40.2^^68^664^11
 ;;^UTILITY(U,$J,358.3,10182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10182,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,10182,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,10182,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,10183,0)
 ;;=L40.3^^68^664^255
 ;;^UTILITY(U,$J,358.3,10183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10183,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,10183,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,10183,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,10184,0)
 ;;=L40.4^^68^664^157
 ;;^UTILITY(U,$J,358.3,10184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10184,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,10184,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,10184,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,10185,0)
 ;;=L40.8^^68^664^252
 ;;^UTILITY(U,$J,358.3,10185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10185,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,10185,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,10185,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,10186,0)
 ;;=L40.9^^68^664^254
